NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Beta Pharma

Beta Pharma

Private
Princeton, New JerseyHealthcare & Life Scienceshttp://betapharma.com/

Last Round

Private Placement

Dec 17, 2020

Est. Valuation

$6.25B

Total Funding Raised

$48.6M

Company Overview

Beta Pharma is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of innovative late-stage therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oncologytargeted therapylung cancernon-small-cell lung cancerNSCLCtyrosine kinase inhibitorTKIbiopharmaceuticalcontract research organizationCROCDK4/6 inhibitordrug discoverycontract development and manufacturingCDMOprecision medicinepharma pipelinecancer drug developer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beta Pharma Comparables

Compare Beta Pharma with similar companies based on industry and business-model similarity.

Beta Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AstraZeneca
82%
Betta Pharmaceuticals Co., Ltd.
82%
Hansoh Pharmaceutical Group Co., Ltd.
79%

Beta Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementDec 17, 2020
IPONov 7, 2016
Series BJun 14, 2013
Series AJun 11, 2010

Beta Pharma Investors

Notable investors and investment history

Beta Pharma investors
InvestorRounds
Lilly Asia VenturesSeries A
HongShanSeries B
China Everbright LimitedSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors increased 3071% MoM, reaching 1.3K.

  • Jan 15, 2025

    Monthly visitors grew 103% MoM.

Beta Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beta Pharma Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Beta Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range39
Year Founded1996
Last FundingDec 17, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.